HIV Treatment Bulletin - Vol. 6, No. 7, July 2005
Gregg Gonsalves, GMHC

In November 2003, a small group of people living with AIDS, drug users, women and gay men met with the Director General of the World Health Organization Dr. Jong Wook-Lee and the new head of the HIV/AIDS Department, Dr. Jim Kim.  This was the first meeting in the history of the epidemic between a Director General and a delegation of PLWHAs from around the world.

One of the priorities for the activists at that meeting was the inclusion of methadone on the WHO’s Model List of Essential Medicines, since this drug is life saving for those struggling with addiction and is a key adjunctive therapy with antiretroviral treatment for drug users.

The push for methadone came from the activists from Eastern Europe and the Newly Independent States and from Southeast Asia.

On 30 June 2005, in what is a victory for drug users, people with AIDS, and all who care about them, the WHO put methadone (and buprenorphine as a medicine with a similar clinical performance within a pharmacological class) on the WHO Model (Complementary) List of Essential Medicines.

“Complementary” list is used for medicines when specialised diagnostic or monitoring facilities and/or specialist medical care and/or specialist training are needed.

Another significant achievement is introduction of a new section in the WHO Model List of Essential Medicines, namely - Medicines used for substance dependence (programmes). This is an opening for other medicines used for treatment of substance dependence, including alcohol.

Source: Letter from Vladimir  Poznyak, M.D., Ph.D. Department of Mental Health and Substance Abuse (MSD), WHO, Geneva.

050710
IB050607-11

©2005. I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7407 8488 F: +44 (0) 20 7407 8489

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, Bridgestone / Firestone Trust, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.